Table 2—

Anthropometric, clinical and polysomnographic data of patients with and without daytime sleepiness

ESS<10ESS>10SL>20SL<20
Subjects n25233018
Age yrs49.6±3.049.2±2.353.8±2.442.1±2.1 **
BMI kg·m−231.3±1.232.8±1.331.8±1.032.4±1.7
AHI n·h−131.6±5.837.9±5.437.1±5.230.5±6.2
Minimal Sa,O2 %74.6±2.472.9±1.874.9±1.872.1±2.7
TTS min426.1±17.4446.8±13.9416.6±14.3468.5±15.7 **
WASO min141.1±18.5111.8±13.7147.6±15.092.7±16.4**
SE %75.7±3.280.2±2.374.4±2.583.7±2.8**
Sleep stage change n264.0±25.0298.2±19.4290.5±21.3263.7±23.9
Awakening n17.5±2.119.6±3.319.4±2.317.0±3.4
Arousal n181.9±21.5209.3±28.5180.8±20.3218.7±32.6
SL min26.7±2.420.5±2.531.4±1.411.1±1.4**
SSS1.9±0.12.6±0.2 **2.1±0.22.5±0.12
ESS7.2±0.413.8±0.79.8±0.711.4±1.1
VAS1.3±0.32.5±0.3* *1.6±0.32.4±0.4
  • Data presented as mean±se unless otherwise stated

  • SL: mean sleep latency in the maintenance wakefulness test

  • ESS: Epworth Sleepiness Scale

  • BMI: body mass index

  • AHI: apnoea/hypopnoea index

  • TST: total sleep time

  • WASO: wake after sleep onset

  • SE: sleep efficiency

  • SSS: Stanford Sleepiness Scale

  • VAS: Visual Analogue Scale

  • AAC; alpha attenuation coefficient

  • **: p<0.01 Mann Whitney U test